Deciding What to Commercialize in Microbial Biologics to Ensure Successful Products & Less Wasted Resources
- Evaluating scientific credibility, field relevance, and customer trust as go and/or no-go criteria
- Applying early microbiome analysis to focus development on products that work under real grower conditions
- Balancing innovation with commercial risk when choosing what moves from R&D into product pipelines